NCT06276491 2026-03-17Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid TumorsXencor, Inc.Phase 1 Recruiting282 enrolled
NCT02499952 2022-07-11Pembrolizumab in Subjects With Incurable Platinum-Refractory Germ Cell TumorsHoosier Cancer Research NetworkPhase 2 Terminated12 enrolled 14 charts
NCT04283773 2021-09-08Immunohistochemical Evaluation of Protein P16 Expression in Ovarian Germ Cell Tumors.Assiut UniversityCompleted62 enrolled 10 charts